Cresset has announced that the Centre for Chemical Biology and Therapeutics (CCBT) at The Institute for Stem Cell Biology and Regenerative Medicine (inStem) has taken a three year license for use of ...
CAMBRIDGE, England--(BUSINESS WIRE)--PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a structural biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results